We examined six radioimmunoassay procedures for measuring primary bile acids in human serum (two 3H-labeled and four 1251-labeled). A significant (p < 0.01) correlation was observed between measurements in the assay both for cholic acid and chenodeoxycholic acid, at low and high concentrations of serum bile acids. All kits were acceptable with respect to accuracy, precision, stability, and analytical recovery. All six procedures gave similar results for chenodeoxycholic and cholic acid in sera of 80 healthy subjects; the agreement was also close when the two primary bile acids were compared with their sum in serum. Normal values ranged from 0.4 to 2.5 tmol/L for conjugated chenodeoxycholic acid and from 0.3 to 1.5 tmol/L for conjugated cholic acid. The 1251 assays do not require liquid-scintillation equipment but 1251 induces a decrease in the affinity constant of antibody. The sensitivity of the assays was still adequate for measuring bile acids in the serum of healthy fasting persons and liver-disease patients. At present, the diagnostic significance of information on bile acid concentration in serum is still uncertain (4, 5) , but many authors have proposed that such information is an index to liver function (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) .
The recent development of radioimmunoassays (RIA)2 for bile acids in serum (11) (12) (13) (14) (15) (16) (17) (18) (19) allows their more convenient determination; however, RIA techniques require standardization and validation before values from different sources can be compared. Tritiated bile acids were first used as tracers (11), but recently 1251 has been introduced (18) , to avoid liquid scintillation counting and to improve the specific activity of the tracer. Those authors found that the antibody titer increased 50-to 500-fold over that used in the tritium assay but sensitivity was maintained (18) . Methods proposed by different authors differ with respect to labeled antigen, antibody specificity, whether or not bile acids are extracted from the serum sample, and the separation of free and antibody-bound antigen.
Here we compare two tritiated RIAs, specific for cholic (CCA) and chenodeoxycholic (CCDCA) acid conjugates, developed in our laboratory and validated by us (15) noassays: two for CCA, one for CCDCA, and one for primary bile acids (cholic and chenodeoxycholic acid).
We also discuss the application of such techniques to a selected population of healthy adult subjects.
Materials and Methods

1251Procedure
The following bile acid RIA kits were either purchased or obtained by donation: Each antiserum was found to be highly specific for each glycine-and taurine-conjugated bile acid. Studies on cross-reaction, parallelism, and recovery, to access reproducibility, precision, and accuracy, have been reported (15) . The RIA procedure was the same as in that paper, except that a final volume of 0.4 mL/tube was used instead of 1.0 mL, to make our assay conditions as comparable as possible to the commercial ones. Table 1 summarizes the above procedures.
Sample Preparation
The assay developed in our laboratory was performed directly on serum samples, without previous extraction of bile acids; results of studies performed on the same sera with and without extraction of bile acids with ethanol (0.1 mL of serum plus 0.9 mL of ethanol)
were closely related (unpublished data 
Instruments
For the 3H-RIA, the radioactivity of the free count (su- and low bile acid concentrations, were established by gas chromatography (20) . Ten aliquots of each pool sera were titered in an assay and these data were used to assess intra-assay variance (Table 3) . These pools were used as quality controls for subsequent routine assays. The inter-assay variance found for the pools is also shown in Table 3 .
Analytical recovery for 10 samples of normal serum, to which known amounts of cholyglycine and chenodeoxycholyiglycine were added, ranged from 90 to 109% for all the methods assessed; parallelism was assessed by use of a sample with high bile acid concentration, diluted several fold, The Dickinson kit for the four primary bile acids presents an enormous difference between the glyco-and tauro-conjugated forms; the cross reaction for glycocholic acid is 50% less with respect to the corresponding taurocholic acid (Table 4) .
Intermethod Comparison
Serum samples from 25 fasting subjects were assayed for Purity. The reagents in the Nordic Lab kits are in a lyophilized form; those in the other kits are in solution, ready for use. We assessed the purity of the tracer by measuring the radiochemical purity by scanning zones of thin-layer chromatograms on silica gel plates developed with benzene/ethanol/acetic acid (60/30/1 by vol), both on a newly acquired kit and on one at its expiration date. All the tracers were more than 95% pure.
Bile acids in the serum of healthy subjects. glycol. The 3H-RIA method, even though involving a labeled antigen with a lower specific activity than in the commercial kits, is more sensitive (2-5 pmol/tube). This can be explained both by a higher affinity constant of the antibody used (Table 3) One must also consider the different response between the glyco-and tauro-conjugated forms. In childhood there may be a preferential conjugation with taurine over glycine (23) . Furthermore, in patients with bile acid malabsorption, the serum becomes enriched during the day with the glyco-conjugated forms (24) . Despite the heterogeneity of the antibodies compared, we noted a good correlation for both high and low values as measured by the different kits. To improve the quality of the assay, it will be necessary to develop new antigens in which the conjugating protein does not mask the specific bile acid function, such as the amino acid side chain and the 3,7,12-hydroxy groups; only in this way it will be possible to produce specific antibodies for an individual bile acid. We emphasize that the Nordic Lab and Becton Dickinson kits do not include information regarding the cross reactivity with sulfated bile acids, which can be as much as 15% of the total bile acids in normal subjects and 70% in patients with cholestasis (7). All the seem to provide reliable results; the insignificant differences in the mean values are probably accounted for by the different specificity of the antisera used.
Therefore, values ranging from 0.4 to 2.5 lLmolfL for conjugated chenodeoxycholic acid and from 0.3 to 1.5 Mmol/L for conjugated cholic acid can be considered normal.
In conclusion, all these commercially available methods are suitable for measuring serum bile acids. Use of 125! tracer has remarkably simplified the method and decreased costs without, however, increasing sensitivity with respect to that of the corresponding 3H methods. The purity of the 1251-labeled antigens is satisfactory, as is also their specific activity as indirectly measured by reaction with our antisera previously titred with a 3H-labeled bile acid for which the specific activity is well known (5 kCi/mol).
For all 1251 tracers assessed, the antibody titer increased by about 30-to 50-fold (unpublished data).
With respect to which bile acid is most useful in liver disease diagnosis-i.e., only one primary bile acid, the sum of them, or other bile acids-this problem is beyond the scope of this paper, but it will be ascertained from extensive application of these methods to hepatobiliary disease.
